跳至主要内容
临床试验/NL-OMON48870
NL-OMON48870已完成不适用

Effectiveness of Continuous Glucose Monitoring versus Stepped Care with HypoAware, a Web-Based PsychoEducational Intervention, and adding CGM as needed, in Adult Type 1 Diabetes with Impaired Hypoglycemia Awareness: ECSPECT-HYPO trial - ECSPECT-HYPO trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 124 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 18 years or older
  • - Type 1 diabetes, treated with either continuous subcutaneous insulin infusion
  • (CSII) or multiple daily insulin injections (MDI)
  • - Impaired awareness of hypoglycemia, as defined by at least one of the
  • following criteria: Gold criteria (i.e., with a Gold score >=4), or one or more
  • severe hypoglycemic events (defined as events requiring external assistance)
  • the past two years

排除标准

  • - Renal insufficiency, with glomerular filtration rate (GFR) < 30 mL/min
  • - History of myocardial infarction in the last 3 months
  • - Current untreated proliferative diabetic retinopathy
  • - Current (treatment for) malignancy
  • - Current severe psychiatric disorders, in the opinion of the investigator
  • - Current substance abuse or alcohol abuse (men >21 units/week, women >14
  • units/week)
  • - Pregnancy or pregnancy wish
  • - Current use of FreeStyle Libre, acquired < 3 months prior to screening for
  • problems with hypoglycemia*s
  • - Any hearing or vision impairment that could hinder perception of the glucose
  • display and alarms, or otherwise incapable of using a (RT-)CGM, in the opinion
  • of the investigator
  • - Poor command of the Dutch language or any (mental) disorder that precluded
  • full understanding of the purpose and instructions of the study
  • - No accessibility to a computer
  • - Any known or suspected allergy to trial-related products

研究者

相似试验

Effectiveness of Continuous Glucose Monitoring... | 临床试验